Lesinidase alfa
Lesinidase alfa Uses, Dosage, Side Effects, Food Interaction and all others data.
Lesinidase alfa is under investigation in clinical trial NCT02324049 (Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)).
| Trade Name | Lesinidase alfa |
| Generic | Lesinidase alfa |
| Lesinidase alfa Other Names | Lesinidase alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lesinidase alfa
